U.S. Markets close in 3 hrs 6 mins

ABIOMED, Inc. (ABMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
162.31+2.52 (+1.58%)
As of 12:54PM EDT. Market open.
People also watch
ALGNABAXNUVAEWANGO

ABIOMED, Inc.

22 Cherry Hill Drive
Danvers, MA 01923
United States
978-646-1400
http://www.abiomed.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees908

Key Executives

NameTitlePayExercisedAge
Mr. Michael R. MinogueChairman, Pres & CEO1.58M11.66M50
Dr. David M. Weber Ph.D.Chief Operating Officer650.45k9.91M56
Mr. Michael G. HowleyVP & GM of Global Sales574.37k3.24M53
Mr. William J. BoltSr. VP of Global Quality, Regulatory & Clinical Operations567.42k3.12M65
Dr. Thorsten SiessChief Technology OfficerN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. It also manufactures and sells AB5000 circulatory support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, the company engages in the research, development, prototyping, and the pre-serial production of a percutaneous expandable catheter pump, which enhances blood circulation from the heart with an external drive shaft. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Japan. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.

Corporate Governance

ABIOMED, Inc.’s ISS Governance QualityScore as of September 1, 2017 is 6. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 7; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.